CHC Healthcare Group (TPE:4164) Cyclically Adjusted Revenue per Share: NT$ (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4164 CHC Healthcare Group TPE:4164
79 GF Score
Price NT$26.05
GF Value NT$49.11
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is CHC Healthcare Group Cyclically Adjusted Revenue per Share?

CHC Healthcare Group TPE:4164 +0.97% 79 Cyclically Adjusted Revenue per Share is NT$ as of Jun. 2026. GuruFocus rates TPE:4164 with a GF Score™ of 79/100 and a GF Value™ of NT$49.11 (Possible Value Trap). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

CHC Healthcare Group's adjusted revenue per share for the three months ended in Jun. 2026 was NT$6.039. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$ for the trailing ten years ended in Jun. 2026.

During the past 12 months, CHC Healthcare Group's average Cyclically Adjusted Revenue Growth Rate was 4.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of CHC Healthcare Group was 2.90% per year. The lowest was 0.10% per year. And the median was 2.90% per year.

As of today (2026-09-20), CHC Healthcare Group's current stock price is NT$26.05. CHC Healthcare Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was NT$. CHC Healthcare Group's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CHC Healthcare Group was 3.89. The lowest was 1.23. And the median was 2.22.


CHC Healthcare Group  (TPE:4164) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CHC Healthcare Group was 3.89. The lowest was 1.23. And the median was 2.22.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


CHC Healthcare Group Cyclically Adjusted Revenue per Share Related Terms


CHC Healthcare Group Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for CHC Healthcare Group's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CHC Healthcare Group Cyclically Adjusted Revenue per Share Chart

CHC Healthcare Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CHC Healthcare Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

TPE:4164 vs MCK, COR, CAH: Cyclically Adjusted Revenue per Share Comparison

For the Medical Distribution subindustry, CHC Healthcare Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CHC Healthcare Group Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, CHC Healthcare Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where CHC Healthcare Group's Cyclically Adjusted PS Ratio falls into.


TPE:4164
79GF Score
CHC Healthcare Group TPE:4164
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CHC Healthcare Group Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CHC Healthcare Group's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=6.039/333.9520*333.9520
=6.039

Current CPI (Jun. 2026) = 333.9520.

CHC Healthcare Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 2.836 241.428 3.923
201612 5.711 241.432 7.900
201703 3.632 243.801 4.975
201706 3.315 244.955 4.519
201709 3.300 246.819 4.465
201712 4.418 246.524 5.985
201803 2.889 249.554 3.866
201806 4.067 251.989 5.390
201809 4.200 252.439 5.556
201812 3.798 251.233 5.048
201903 3.740 254.202 4.913
201906 4.550 256.143 5.932
201909 5.543 256.759 7.209
201912 3.521 256.974 4.576
202003 3.263 258.115 4.222
202006 3.698 257.797 4.790
202009 4.157 260.280 5.334
202012 2.489 260.474 3.191
202103 3.480 264.877 4.388
202106 2.403 271.696 2.954
202109 2.590 274.310 3.153
202112 4.664 278.802 5.587
202203 3.176 287.504 3.689
202206 3.621 296.311 4.081
202209 4.250 296.808 4.782
202212 4.449 296.797 5.006
202303 4.148 301.836 4.589
202306 4.587 305.109 5.021
202309 3.804 307.789 4.127
202312 7.497 306.746 8.162
202403 3.946 312.332 4.219
202406 5.743 314.175 6.105
202409 4.941 315.301 5.233
202412 5.233 315.605 5.537
202503 5.889 319.799 6.150
202506 5.304 322.561 5.491
202509 5.129 324.800 5.274
202512 6.192 324.054 6.381
202603 5.942 330.213 6.009
202606 6.039 333.952 6.039

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of NT$ mean?
CHC Healthcare Group (TPE:4164) has a Cyclically Adjusted Revenue per Share of NT$ as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on CHC Healthcare Group and its competitors.
Is CHC Healthcare Group's Cyclically Adjusted Revenue per Share too high?
CHC Healthcare Group's current Cyclically Adjusted Revenue per Share is NT$. Overall, CHC Healthcare Group has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CHC Healthcare Group's Cyclically Adjusted Revenue per Share compare to MCK and COR?
CHC Healthcare Group's Cyclically Adjusted Revenue per Share of NT$ can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Distribution company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on CHC Healthcare Group and its competitors. CHC Healthcare Group's current Cyclically Adjusted Revenue per Share is NT$. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CHC Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, CHC Healthcare Group (TPE:4164) is currently considered Possible Value Trap. The stock's GF Value™ is NT$49.11, compared to a current price of NT$26.05 — trading 47% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is NT$. CHC Healthcare Group's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For CHC Healthcare Group (TPE:4164), the current Cyclically Adjusted Revenue per Share is NT$ as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CHC Healthcare Group (TPE:4164) Overvalued in 2026?

Based on GuruFocus' analysis, CHC Healthcare Group stock appears to be undervalued. The current stock price of NT$26.05 is trading 47% below its estimated GF Value™ of NT$49.11. GuruFocus considers CHC Healthcare Group to be Possible Value Trap.

Key valuation signals for TPE:4164:

  • Cyclically Adjusted Revenue per Share: NT$
  • GF Value™: NT$49.11 vs. price of NT$26.05 (47% below fair value)
  • GF Score™: 79/100 with 8 warning signs

No single metric tells the full story. See the TPE:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CHC Healthcare Group Business Description

Address No. 88, Xing’ai Road, Neihu District, Taipei, TWN, 114067
CHC Healthcare Group is a Taiwan-based company engaged in the trading of pharmaceutical products and health food, as well as the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment used in radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, the sale of medical instruments, repairs, maintenance, and other services.
79GF Score

Get the complete analysis for TPE:4164

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$26.05
Price
NT$49.11
GF Value